Correction: Share buybacks in Ericsson during the period April 20 - April 24, 2026

Nordea cancels repurchased shares

Agenda for Essity's Capital Markets Day Accelerating progress by sharpening focus and execution

Beyond Simulation: Sungrow Completes World's First Large-Scale Full-Condition Grid-Forming Extreme Test

OpenLegacy Japan and Deloitte Tohmatsu Form Strategic Alliance to Advance Legacy System Modernization

Securitas AB Interim Report Q1 2026 | January-March

Castle Rock Hormone Health Announces National Franchise Launch with Franchise Sidekick Amid Growing Demand for Longevity Medicine

Bioxodes to present final Phase 2a trial results confirming breakthrough potential of BIOX-101 for intracerebral hemorrhage in poster at...

Quadient and Solix Strengthen SaaS Communications Lifecycle with Expansion of Advanced Enterprise Archiving

Raiffeisenbankengruppe Oesterreich (excluding Raiffeisen Bank International) Selects nCino to Modernise Corporate Lending Across Its...

TEELX Announces Strategic Partnership to Advance AI-Driven Quantitative Trading

Sobi Q1 2026 report: Strong execution and pipeline momentum

Jay Mondo and A&A Sports Group LLC Unveil Visionary Summer Music Campaign

Sungrow Hosts GRES 2026, Showcasing Value-Driven Innovation Across Full Energy Scenarios

Progress on share buyback programme

Market Logic extends DeepSights Personas with synthetic panels and flexible persona generation to redefine audience research at scale

STMicroelectronics brings always-on vision to next-generation personal electronics with new ultralow-power image sensors

Ondo Finance Brings Shareholder Voting Capabilities to Tokenized Securities with Broadridge

Boehringer Ingelheim’s novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful...

Zealand Pharma announces Boehringer Ingelheim's novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6%...